301617.SZ
Shandong Boyuan Pharmaceutical & Chemical Co. Ltd.
SZSE · C 制造业 · CN
CNY 48.11
−2.81%Year over year
Reported trailing growth
- Revenue
- +14.6%
- EBITDA
- —
- EBIT
- -15.0%
- EPS
- -44.2%
- Free cash flow
- —
- Operating cash flow
- -39.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +22.4%
- EBITDA
- +0.9%
- EBIT
- -1.0%
- Net income
- -0.8%
- EPS
- -17.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026